Abstract
Protein therapeutics have drastically changed the landscape of treatment for many diseases by providing a regimen that is highly specific and lacks many off-target toxicities. The clinical utility of many therapeutic proteins has been undermined by the potential development of unwanted immune responses against the protein, limiting their efficacy and negatively impacting its safety profile. This review attempts to provide an overview of immunogenicity of therapeutic proteins, including immune mechanisms and factors influencing immunogenicity, impact of immunogenicity, preclinical screening methods, and strategies to mitigate immunogenicity.
| Original language | English |
|---|---|
| Pages (from-to) | 1637-1654 |
| Number of pages | 18 |
| Journal | Journal of Pharmaceutical Sciences |
| Volume | 108 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2019 |
Keywords
- antibody(s)
- immune response(s)
- immunogenicity
- immunology
- pharmacodynamics
- pharmacokinetics
- protein(s)
Fingerprint
Dive into the research topics of 'Immunogenicity of Protein Pharmaceuticals'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver